DBMZX
Price
$29.96
Change
+$0.05 (+0.17%)
Updated
Jan 17 closing price
Net Assets
1.26B
FSMAX
Price
$94.51
Change
+$0.64 (+0.68%)
Updated
Jan 17 closing price
Net Assets
40.78B
Ad is loading...

DBMZX vs FSMAX

Header iconDBMZX vs FSMAX Comparison
Open Charts DBMZX vs FSMAXBanner chart's image
BNY Mellon Sm/Md Cp Gr Z
Price$29.96
Change+$0.05 (+0.17%)
VolumeN/A
Net Assets1.26B
Fidelity Extended Market Index
Price$94.51
Change+$0.64 (+0.68%)
VolumeN/A
Net Assets40.78B
DBMZX vs FSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DBMZX vs. FSMAX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBMZX is a Buy and FSMAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.8B vs. DBMZX (1.26B). FSMAX pays higher dividends than DBMZX: FSMAX (1.10) vs DBMZX (0.00). DBMZX was incepted earlier than FSMAX: DBMZX (7 years) vs FSMAX (13 years). DBMZX is a more actively managed with annual turnover of: 36.02 vs. FSMAX (18.00). FSMAX has a lower initial minimum investment than DBMZX: FSMAX (0) vs DBMZX (1000). FSMAX annual gain was more profitable for investors over the last year : 26.14 vs. DBMZX (18.28). FSMAX return over 5 years is better than : 48.39 vs. DBMZX (13.44).
DBMZXFSMAXDBMZX / FSMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years13 years-
Gain YTD4.6093.994115%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.26B40.8B3%
Annual Yield % from dividends0.001.10-
Returns for 1 year18.2826.1470%
Returns for 3 years2.9921.4014%
Returns for 5 years13.4448.3928%
Returns for 10 years358.7690.18398%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYEL0.580.02
+2.97%
Lyell Immunopharma
KC9.970.06
+0.61%
Kingsoft Cloud Holdings Limited
BG79.540.14
+0.18%
Bunge Global SA
GENE0.76N/A
N/A
Genetic Technologies Ltd
XENE38.52-1.10
-2.78%
Xenon Pharmaceuticals